Evidence map›Paper›PMID 27484319›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2016

Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.

Ming D Li, Yih-Ing Hser, Zhiwei Chen, Linda Chang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Ming D LiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yih-Ing HserIntegrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Zhiwei ChenAIDS Institute and Department of Microbiology, Research Center for Infection and Immunity, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, People's Republic of China.
Linda ChangDepartment of Medicine (Neurology), John A. Burns School of Medicine, University of Hawaii and the Queen's Medical Center, Honolulu, HI, USA. lchang@hawaii.edu.ORCID 0000-0002-1267-0699
First Affiliated Hospital Zhejiang University · CNInstitute of Infection and Immunity · CAUniversity of California, Los Angeles · USUniversity of Hawaiʻi at Mānoa · US

Funding

STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
Neural Correlates of Working Memory Training For HIV PatientsR01DA035659 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI CHANG, LINDA · 2012 to 2017
$2.8M
Neuroimaging and Mentoring in Drug Abuse ResearchK24DA016170 · NIDA · UNIVERSITY OF HAWAII AT MANOA · PI CHANG, LINDA · 2003 to 2013
$1.8M
Conference Series to Promote Global Health...R13DA035084 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2013 to 2017
$143k
CALDAR Institute on Longitudinal Research Findings and MethodsR13DA024494 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2008 to 2017
$125k
NIDA NIH HHS K24 DA016170NIDA NIH HHS P30 DA016383NIDA NIH HHS R01 DA035659NIDA NIH HHS R13 DA024494NIDA NIH HHS R13 DA035084
6 · The paper itself

Abstract

This special issue contains 20 papers including 3 Perspectives, 1 Brief Report, 6 Invited Reviews, and 10 Original Articles, which highlight the work by presenters at the second meeting of the biennial Conference Series to Promote Global Health held on April 22-24, 2015 in Hangzhou, Zhejiang, China. These papers focused on the prevalent substance misuse of amphetamine-type-stimulants and opioids, and the increasing prevalence of HIV-infection in Asian countries. The Conference Series is sponsored by the National Institute on Drug Abuse of the U.S. National Institutes of Health, with the goal of exchanging knowledge and ideas related to, and promoting international collaborative work on, the prevention and treatment of substance use disorders and HIV-infection, in order to promote health in Asian and Pacific Islanders and other populations.

Indexed as

AsiaChinaCongresses as TopicGlobal HealthHIV InfectionsHumansNational Institute on Drug Abuse (U.S.)Substance-Related DisordersTreatment OutcomeUnited StatesGlobal healthHIVSubstance use disorders

Identifiers

PMID27484319
PMCPMC5419042
OpenAlexW2479507691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.